CVS vs USBC
CVS Health Corp (CVS) versus US BioTec Inc (USBC) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
US BioTec Inc (USBC) is a agricultural inputs company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported USBC revenue for 2023-09-30 was $0. Net income was -$15.3M. Revenue was down 100.0% from 2022-09-30 to 2023-09-30. USBC currently screens at market cap $0.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. USBC currently screens at market cap $0.
Not investment advice. Open the CVS and USBC stock pages for the full models.
Not investment advice.